EpiCept CorpShs News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

11.01.10	EpiCept Announces Commercial Licensing Agreement for Ceplene® with Meda in Europe and Pacific Rim (Businesswire)
15.12.09	EpiCept Provides Clinical and Business Update on Ceplene Program (Businesswire)
11.12.09	EpiCept to Present at Lippert/Heilshorn & Associates Life Sciences Virtual Conference (Businesswire)
03.09.09	EpiCept’s Ceplene® Highlighted in Two 2008 European Union Drug Approval Reports (Businesswire)
29.06.09	EpiCept Shares on the OMX Nordic Exchange Transferred Back to Ordinary Position from Observation Segment (Businesswire)
02.06.09	EpiCept Partners With IDIS For Ceplene® Named Patient/Compassionate Use Program (Businesswire)
28.05.09	EpiCept Announces Presentation of New Crinobulin Data at 2009 American Society of Clinical Oncology Annual Meeting (Businesswire)
27.02.09	EpiCept Corporation Reports Fourth Quarter and Full Year 2008 Operating and Financial Results (Businesswire)
05.02.09	EpiCept Corporation Announces Pricing of Public Offering (Businesswire)
02.02.09	EpiCept Receives Permission to File Ceplene® NDA (Businesswire)
12.01.09	EpiCept Discontinues Drug Discovery Operations and Reduces Workforce (Businesswire)
04.12.08	EpiCept Reports New Data on Benefits of Maintenance Therapy With Ceplene® and interleukin-2 For AML Patients At ASH Annual Meeting (Businesswire)
15.09.08	EpiCept Amends DURECT Bupivacaine Patch Licensing Agreement (Businesswire)
17.07.08	EpiCept and GNI Partner to Develop Anti-Viral Hepatitis Drug in Asia (Businesswire)
16.07.08	EpiCept Announces Pricing of Public Offering (Businesswire)
23.06.08	EpiCept Announces Proposed Public Offering (Businesswire)
15.05.08	Notice of the Annual Meeting of Stockholders of EpiCept Corporation (Businesswire)
15.05.08	EpiCept Corporation Reports First Quarter 2008 Operating and Financial Results (Businesswire)
07.04.08	EpiCept Announces Receipt of Nasdaq Notice (Businesswire)
06.03.08	EpiCept Corporation Announces Pricing of Public Offering (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V